Approval · Notice of Compliance 21636 · 2018
CRESEMBA: Notice of Compliance 21636
Issued December 19, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21636
- Date
- December 19, 2018
- Company
- Avir Pharma IncBlainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- ISAVUCONAZONIUM SULFATE 186.3 MG per CAP
- ISAVUCONAZONIUM SULFATE 372.6 MG per VIAL